The UK Pancreatic Cancer Research Fund (PCRF) has awarded £1.2 million to seven research projects addressing pancreatic cancer.
This is the fourth year that the charity has allocated over £1 million for research projects and brings its research portfolio spend to over £9 million, with an additional £2 million committed to the world's first national pancreas tissue bank.
The new projects span early diagnosis, potential new treatments, and fundamental research to find out why immunotherapy does not yet work with pancreatic cancer. They include the progression of promising virotherapy research, a unique technology to tag unwanted proteins and trigger their destruction, and testing whether machine learning techniques can help identify those at risk from developing the disease.
The seven recipients are: Dr Richard Clarkson from Cardiff University; Professor Laura Itzhaki from the University of Cambridge; Dr Gunnel Halldén from Queen Mary University of London; Dr Naomi Walsh from Dublin City University, Ireland; Dr Laura Woods from the London School of Hygiene & Tropical Medicine; Professor Maeve Lowery from Trinity College Dublin, Ireland; and Professor Hemant Kocher from Queen Mary University of London.
